physostigmine has been researched along with Psychotic Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STOLIAROV, GV | 1 |
| Luchins, DJ | 1 |
| Feinsilver, DL | 1 |
| Risch, SC | 1 |
| Edelstein, P; Garver, DL; Hirschowitz, J; Kanter, DR; Schultz, JR | 1 |
| Karan, RS; Pandhi, P; Ravishankar, P | 1 |
| Barchas, JD; Berger, PA; Davis, KL; Hollister, LE | 1 |
| Berger, PA; Davis, KL | 1 |
| Bastani, JR | 1 |
| Davis, JM; Huey, L; Janowsky, DS; Judd, LL | 1 |
| Anderson, MH; Lynch, H | 1 |
| Dahm, JB; Trenckmann, U | 1 |
| Gillin, JC; Huey, L; Janowsky, DS; Rausch, J; Risch, SC; Ziegler, MG | 1 |
| Alpert, M; Friedhoff, AJ | 1 |
| Bilikiewicz, T; Galuszko, P | 1 |
1 trial(s) available for physostigmine and Psychotic Disorders
| Article | Year |
|---|---|
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia | 1978 |
14 other study(ies) available for physostigmine and Psychotic Disorders
| Article | Year |
|---|---|
[ON ATROPINE PSYCHOSES].
Topics: Atropine; Humans; Mental Disorders; Morphine; Physostigmine; Pilocarpine; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology | 1963 |
Developments in biological psychiatry: clinical applications to the major psychoses.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Humans; Hydrocortisone; Lithium; Neurotransmitter Agents; Physostigmine; Psychotic Disorders; Research; Schizophrenia; Tomography, X-Ray Computed | 1982 |
Antipsychotic medications: guidelines for use in emergencies.
Topics: Adult; Aged; Antipsychotic Agents; Child; Delirium; Dopamine Antagonists; Dyskinesia, Drug-Induced; Emergencies; Family Practice; Histamine H1 Antagonists; Humans; Hypotension; Parasympatholytics; Physostigmine; Psychotic Disorders; Sympathomimetics | 1982 |
beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms.
Topics: Adrenocorticotropic Hormone; beta-Endorphin; Depressive Disorder; Double-Blind Method; Endorphins; Humans; Physostigmine; Psychotic Disorders; Random Allocation; Receptors, Cholinergic | 1982 |
Physostigmine and lithium response in the schizophrenias.
Topics: Adult; Double-Blind Method; Female; Humans; Infusions, Parenteral; Lithium; Male; Physostigmine; Premedication; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1981 |
Effect of muscarinic receptor agonists on animal models of psychosis.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Muscarinic Agonists; Physostigmine; Pilocarpine; Psychotic Disorders; Rats; Rats, Wistar; Stereotyped Behavior | 2000 |
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
Topics: Biogenic Amines; Bipolar Disorder; Humans; Huntington Disease; Movement Disorders; Parasympathetic Nervous System; Physostigmine; Psychotic Disorders; Research Design; Schizophrenia; Tranquilizing Agents | 1975 |
Physostigmine treatment of tricyclic overdosage in psychosis.
Topics: Adult; Alcoholism; Antidepressive Agents, Tricyclic; Humans; Male; Middle Aged; Physostigmine; Psychotic Disorders | 1979 |
Methylphenidate and physostigmine as diagnostic tools.
Topics: Affective Symptoms; Humans; Methylphenidate; Physostigmine; Psychotic Disorders | 1978 |
Atropine coma therapy in psychiatry: clinical observations over a 20-year period and a review of the literature.
Topics: Adolescent; Adult; Aged; Antidotes; Anxiety; Atropine; Bipolar Disorder; Coma; Electronarcosis; Humans; Indiana; Middle Aged; Neurotic Disorders; Physostigmine; Psychiatric Nursing; Psychotherapy; Psychotic Disorders; Retrospective Studies; Schizophrenia | 1975 |
[Neuroleptic malignant syndrome].
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Physostigmine; Psychotic Disorders | 1991 |
Physostigmine-induced epinephrine release in patients with affective disorder.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Diagnosis, Differential; Epinephrine; Humans; Infusions, Parenteral; Middle Aged; Norepinephrine; Physostigmine; Psychotic Disorders | 1986 |
A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
Topics: Amphetamine; Animals; Brain; Brain Chemistry; Dopamine; Humans; Models, Biological; Parasympatholytics; Parkinson Disease; Physostigmine; Psychopharmacology; Psychotic Disorders; Rats; Receptors, Adrenergic; Receptors, Cholinergic; Receptors, Drug; Tranquilizing Agents | 1973 |
[Atropine coma and its therapeutic value].
Topics: Atropine; Chronic Disease; Coma; Humans; Mental Disorders; Neurotic Disorders; Physostigmine; Psychotic Disorders; Schizophrenia | 1970 |